Details for New Drug Application (NDA): 021369
✉ Email this page to a colleague
NDA 021369 describes CODEPREX, which is a drug marketed by Lannett Co Inc and is included in one NDA. Additional details are available on the CODEPREX profile page.
The generic ingredient in CODEPREX is chlorpheniramine polistirex; codeine polistirex. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine polistirex; codeine polistirex profile page.
The generic ingredient in CODEPREX is chlorpheniramine polistirex; codeine polistirex. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine polistirex; codeine polistirex profile page.
Summary for 021369
| Tradename: | CODEPREX |
| Applicant: | Lannett Co Inc |
| Ingredient: | chlorpheniramine polistirex; codeine polistirex |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION, EXTENDED RELEASE;ORAL | Strength | EQ 4MG MALEATE/5ML;EQ 20MG BASE/5ML | ||||
| Approval Date: | Jun 21, 2004 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
